National Center for Biotechnology Information
Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors
. 2022 Oct 7;12(9):900-908.
doi: 10.1093/tbm/ibac031.
Affiliations
Expand
...
Breast cancer diagnosis in Inner-City African American and Hispanic women: The importance of early screening
Purpose:
To evaluate the diagnosis of breast cancer in inner-city African-American and Hispanic women under age 50 to support the im...
The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer
Purpose:
To investigate the impact of race/ethnicity on surgical outcomes following pancreaticoduodenectomy for pancreatic cancer.
...
Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic
Background:
Influenza vaccination rates are decreasing in the United States. Disinformation surrounding COVID-related public health protections an...
Health-related information needs and preferences for information of individuals with cardiovascular disease from underserved populations: A systema...
Objective:
This systematic review aimed to identify the information needs and preferences of individuals with CVD from underserved populations.
M...
Posttraumatic Growth and Life Course Stress Predict Dyadic Wellbeing Among Sexual and Gender Minority (SGM) and non-SGM Couples Facing Cancer
Objective:
This study examined: 1) Differences among sexual and gender minority (SGM) and non-SGM couples’ life course stress,...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
